This topic contains a solution. Click here to go to the answer

Author Question: Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than ... (Read 84 times)

azncindy619

  • Hero Member
  • *****
  • Posts: 562
Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than an infusion of mycophenolate (CellCept)?
 
  a. Muromonab-CD3 is administered for shorter time periods than is mycophenolate.
  b. Muromonab-CD3 is administered in much higher dosages than is mycophenolate.
  c. Mycophenolate is an antiproliferative agent and muromonab-CD3 is a polyclonal antibody.
  d. Mycophenolate is a synthetically manufactured drug and muromonab-CD3 is produced using mouse proteins.

Question 2

Which precaution is most important to teach a patient taking an antiproliferative agent to manage an autoimmune disease?
 
  a. Do not stop taking this drug for any reason or your organs will become atrophied.
  b. Keep all health care appointments because your risk for cancer is now increased.
  c. Avoid foods and drinks containing caffeine because your risk for high blood pressure is greatly increased.
  d. Make certain someone is with you when you take this drug because allergic reactions are common and often delayed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alexanderhamilton

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B




azncindy619

  • Member
  • Posts: 562
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


xiazhe

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library